Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Beats on EPS, Stock Down 0.72%

Vertex Pharmaceuticals reported a strong earnings surprise with an EPS of $0.70, significantly exceeding expectations. However, the stock reacted negatively, declining by 0.72%. This suggests that despite the positive earnings, investors may have concerns about other aspects of the company's performance or future outlook.